The patients recovered from the COVID-19 reduce lung capacity by up to 30 percent and have problems such as shortness of breath to the brisk and fast pace, according to a study implemented by the Hospital Authority of Hong Kong (China).
In an interview for the South China Morning Post, Owen Tsang Tak-yin, medical director of the Authority’s Center for Infectious Diseases at Princess Margaret Hospital, explained that after following up on recovered patients from Covid-19 they discovered that they were no longer capable to carry out activities that they used to do normally.
“They gasp if they speed up,” Tsang explained, adding that after recovery, “some patients may have a reduction in their lung capacity of between 20% and 30%.”
It may interest you: What is Coronavirus? How is Corona Virus transmitted?
At the moment, patients with covid-19 are treated with Kaletra, a drug used for HIV, as well as with Ribavirin, used in patients with hepatitis C, and with Interferon. In addition, in the coming weeks, Hong Kong hospitals will begin clinical trials with remdesivir, originally developed to treat Ebola, to see how effective it is against the new virus.
With information from RT